Sequential pembrolizumab and AVD are highly effective at any PD-L1 expression level in untreated Hodgkin lymphoma
Autor: | Allen, Pamela B. 1, ∗, Lu, Xinyan 2, Chen, Qing 2, O’Shea, Kaitlyn 2, Chmiel, Joan S. 2, Slonim, Liron Barnea 2, Sukhanova, Madina 2, Savas, Hatice 2, Evens, Andrew M. 3, Advani, Ranjana 4, Pro, Barbara 2, 5, Karmali, Reem 2, Palmer, Brett 2, Bayer, Robert A. 2, Eisner, Robert M. 2, Mou, Eric 4, 6, Dillehay, Gary 2, Gordon, Leo I. 2, Winter, Jane N. 2 |
---|---|
Zdroj: | In Blood Advances 27 June 2023 7(12):2670-2676 |
Databáze: | ScienceDirect |
Externí odkaz: |